These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 10581081

  • 1. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.
    Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR.
    Nat Med; 1999 Dec; 5(12):1390-5. PubMed ID: 10581081
    [Abstract] [Full Text] [Related]

  • 2. Angiogenesis in embryos and ischemic diseases.
    Breier G, Damert A, Plate KH, Risau W.
    Thromb Haemost; 1997 Jul; 78(1):678-83. PubMed ID: 9198238
    [Abstract] [Full Text] [Related]

  • 3. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K.
    Cancer Res; 2000 Jan 15; 60(2):203-12. PubMed ID: 10667560
    [No Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S.
    Med Sci Monit; 2000 Jan 15; 6(5):1047-52. PubMed ID: 11208453
    [Abstract] [Full Text] [Related]

  • 5. VEGF is major stimulator in model of choroidal neovascularization.
    Kwak N, Okamoto N, Wood JM, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 2000 Sep 15; 41(10):3158-64. PubMed ID: 10967078
    [Abstract] [Full Text] [Related]

  • 6. Growth factors and diabetic retinopathy.
    Paques M, Massin P, Gaudric A.
    Diabetes Metab; 1997 Apr 15; 23(2):125-30. PubMed ID: 9137900
    [Abstract] [Full Text] [Related]

  • 7. VEGFs, receptors and angiogenesis.
    Veikkola T, Alitalo K.
    Semin Cancer Biol; 1999 Jun 15; 9(3):211-20. PubMed ID: 10343072
    [Abstract] [Full Text] [Related]

  • 8. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Oct 15; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N.
    Recent Prog Horm Res; 2000 Oct 15; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [Abstract] [Full Text] [Related]

  • 11. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
    Giorgetti-Peraldi S, Murdaca J, Mas JC, Van Obberghen E.
    Oncogene; 2001 Jul 05; 20(30):3959-68. PubMed ID: 11494124
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor: environmental controls and effects in angiogenesis.
    Hlatky L, Hahnfeldt P, Tsionou C, Coleman CN.
    Br J Cancer Suppl; 1996 Jul 05; 27():S151-6. PubMed ID: 8763869
    [No Abstract] [Full Text] [Related]

  • 13. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
    Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E.
    Invest Ophthalmol Vis Sci; 1996 Feb 05; 37(2):290-9. PubMed ID: 8603833
    [Abstract] [Full Text] [Related]

  • 14. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
    Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, Okamoto N, Hofmann F, Wood JM, Campochiaro PA.
    Am J Pathol; 2000 Feb 05; 156(2):697-707. PubMed ID: 10666398
    [Abstract] [Full Text] [Related]

  • 15. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):383-8. PubMed ID: 11756651
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
    Aiello LP.
    Invest Ophthalmol Vis Sci; 1997 Aug 08; 38(9):1647-52. PubMed ID: 9286253
    [No Abstract] [Full Text] [Related]

  • 17. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 08; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 08; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA, Wu J, Vasilcanu D, Rosengren L, All-Ericsson C, van der Ploeg I, Menu E, Girnita L, Axelson M, Larsson O, Seregard S, Kvanta A.
    Invest Ophthalmol Vis Sci; 2008 Jun 08; 49(6):2620-6. PubMed ID: 18515591
    [Abstract] [Full Text] [Related]

  • 20. VEGF receptor signal transduction.
    Matsumoto T, Claesson-Welsh L.
    Sci STKE; 2001 Dec 11; 2001(112):re21. PubMed ID: 11741095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.